RNLX - Renalytix

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Renalytix files $200M mixed securities shelf
• Renalytix jumps 38% after FDA nod for lead product
• Renalytix AI GAAP EPS of -$0.14 in-line, revenue of $1.2M misses by $0.08M
• Renalytix sheds 17% as FDA extends review on lead product
• Renalytix announces $20.3M private placement
• Renalytix, partners get $10M EU grant to advance treatments for kidney disease
• Renalytix AI GAAP EPS of -$0.16, revenue of $0.97M
• Renalytix AI GAAP EPS of -$0.78 misses by $0.16, revenue of $2.9M
• Renalytix stock touches record low on wider quarterly loss
• Renalytix AI GAAP EPS of -$0.20, revenue of $0.81M
• Renalytix surges on launching $30M financing package
• Renalytix AI GAAP EPS of -$0.21 misses by $0.04, revenue of $0.84M misses by $0.21M
• Renalytix's KidneyIntelX improves kidney function prediction vs standard of care
• Renalytix, American Diabetes Association in pact for kidney health among diabetics
• Renalytix AI EPS in-line, misses on revenue
• Renalytix AI reports FY results
• Renalytix AI EPS beats by $0.06, misses on revenue
• Bio-Techne and Kantaro Biosciences get Health Canada authorization for COVID-19 test kit
• Renalytix AI shares surge 15% on 10-year U.S. contract for KidneyIntelX testing
• RenalytixAI and Joslin Diabetes Center ink exclusive option agreement